Completed

3

300

Europe, Canada, US, RoW

89Zr-girentuximab, 89Zr-TLX250, 89Zr-DFO-TFP-girentuximab (GTX)

Telix Pharmaceuticals (Innovations) Pty Limited, Telix International Pty Ltd

Clear Cell Renal Cell Carcinoma

10/22

11/22

Recruiting

3

250

Europe, US, RoW

177Lu-Edotreotide (Peptide Receptor Radionuclide Therapy) PRRT, 177Lu-DOTATOC 177Lu-Edo, CAPTEM (Capecitabine and Temozolomide), Amino-Acid Solution, Arginine-Lysine Solution, Everolimus, FOLFOX (Folinic acid + Fluorouracil + Oxaliplatin)

ITM Solucin GmbH

Neuroendocrine Tumors

06/27

09/27

Recruiting

3

6000

Europe, Canada, Japan, US, RoW

Imlunestrant, LY3484356, Tamoxifen, Anastrozole, Letrozole, Exemestane

Eli Lilly and Company

Breast Neoplasms

10/27

03/32

Active, not recruiting

2

16

US

Telatinib, Keytruda, pembrolizumab

Andrew Hendifar, MD, EOC Pharma

Gastric Cancer, Hepatocellular Carcinoma

02/24

02/25

Recruiting

2

88

US

Anastrozole, Anastrazole, Arimidex, ICI D1033, ICI-D1033, ZD-1033, Therapeutic Conventional Surgery, Trastuzumab Deruxtecan, DS-8201, DS-8201a, Enhertu, Fam-trastuzumab Deruxtecan-nxki, WHO 10516

Jonsson Comprehensive Cancer Center, Translational Research in Oncology-U.S, Daiichi Sankyo Co., Ltd.

Early-stage Breast Cancer, Hormone Receptor Positive Breast Carcinoma, Invasive Breast Cancer, Stage II Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer, Stage III Breast Cancer

09/25

09/25

Recruiting

N/A

600

Canada

Implementation of WAPPS-Hemo personalized dosing regimen

McMaster University

Hemophilia A, Hemophilia B

09/22

09/23

Recruiting

N/A

36

RoW

High concentration Oxygen therapy, Control: Room Air or Low concentration Oxygen

Chinese University of Hong Kong

Chronic Subdural Hematoma, Recurrence, Oxycephaly

12/23

12/24

Recruiting

N/A

10

 

Northern Sydney Local Health District, Sydney Vital

Neuroendocrine tumours

 

 

Completed

3

765

RoW

TPN171H 2.5mg group, Simmerafil, TPN171H 5mg group, TPN171H 10mg group, Placebo group

Vigonvita Life Sciences

Erectile Dysfunction

02/23

02/23

Active, not recruiting

3

531

RoW

JS001, Nab-Paclitaxel, Placebo

Shanghai Junshi Bioscience Co., Ltd.

Triple-Negative Breast Cancer

12/24

12/25

Recruiting

3

472

RoW

TPN171H, Simmerafil

Vigonvita Life Sciences

Erectile Dysfunction

04/25

04/25

Recruiting

3

360

RoW

PM8002, Nab-Paclitaxel, Placebo

Biotheus Inc.

Triple Negative Breast Cancer(TNBC)

07/27

07/28

Not yet recruiting

3

400

RoW

JSKN003, Capecitabine tablets, Gemcitabine hydrochloride for injection, Vinorelbine tartrate injection, Paclitaxel for injection (albumin-bound type), Docetaxel injection, Eribulin mesylate injection

Jiangsu Alphamab Biopharmaceuticals Co., Ltd

Breast Cancer

04/25

03/29

Recruiting

3

766

RoW

Fluzoparib, Anastrozole, Letrozole, Exemestane, Tamoxifen, Toremifene, Abemaciclib, LHRH agonist

Fudan University

Breast Cancer

05/28

05/31

Active, not recruiting

2/3

549

Europe, RoW

Oral paclitaxel, Liporaxel®, Paclitaxel injection, Taxol®

Daehwa Pharmaceutical Co., Ltd., Daehwa pharmaceutical Co., Ltd.

Recurrent or Metastatic Breast Cancer

02/24

12/25

Recruiting

2/3

254

RoW

SPH4336 Tablets, SPH4336 Tablets Placebo

Shanghai Pharmaceuticals Holding Co., Ltd

Locally Advanced or Metastatic Breast Cancer

03/25

08/25

Recruiting

2

209

RoW

Pyrotinib, Trastuzumab, Albumin paclitaxel

First Affiliated Hospital Xi'an Jiaotong University

HER2-positive Breast Cancer

05/24

10/24

Not yet recruiting

2

33

RoW

TQB3616 capsule+Fulvestrant Injection

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Breast Cancer

05/26

12/26

Recruiting

1

150

RoW

TQB2102 for injection

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.

Breast Cancer

12/25

12/26

Not yet recruiting

N/A

40

NA

Conbercept intravitreal injection

Eye & ENT Hospital of Fudan University

Diabetic Macular Edema, Diabetic Retinopathy, Cataract Diabetic

11/21

01/22

Recruiting

N/A

60

RoW

Active iTBS, Sham iTBS

Central South University

Schizophrenia

08/25

12/25

Recruiting

N/A

10168

RoW

Continuous glucose monitoring (CGM) device

Beijing Tsinghua Chang Gung Hospital, Peking University International Hospital, Wang Jing Hospital, ZhuHai Hospital, Beijing Hospital, Siyang County Hospital of Traditional Chinese Medicine, Second Hospital of Shanxi Medical University, Henan Provincial Chest Hospital, Fuzhou First Hospital, Pinggu Hospital of Beijing Traditional Chinese Medicine Hospital, The First Affiliated Hospital of Anhui University of Chinese Medicine, The First Affiliated Hospital of Zhengzhou University, Mindong Hospital of Ningde, The Fifth Hospital of Xiamen, People's Hospital of Ningxia Hui Autonomous Region, The First People's Hospital of Changzhou, The Fifth hospital of Deyang, Suzhou Municipal Hospital, Tang-Du Hospital, Yiyang Central Hospital, First Affiliated Hospital of Xinjiang Medical University, Peng Ding Shan Shi Zhong Yi Yi Yuan, Yueyang Central Hospital, The First People's Hospital of Lianyungang, Haimen District Traditional Chinese Medicine Hospital, The 910th Hospital, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Beijing Tiantan Hospital, Affiliated Hospital of Jiangsu University, Liaocheng People's Hospital, Beijing Chao Yang Hospital, Jilin City Hospital of Chemical Industry, Creen Hospital-465, Wuhan Central Hospital, Air Force Military Medical University, China, Shanghai Tong Ren Hospital, Beijing Anzhen Hospital, Emergency General Hospital, Beijing Tongren Hospital, Civil Aviation General Hospital, Peking University Shougang Hospital, The First Affiliated Hospital of Anhui Medical University, Chinese PLA Central Hospital

Comprehensive Complication Index

10/25

12/25

Recruiting

N/A

20000

RoW

Evidence Based Cataract Study Group

Cataract, High Myopia

12/26

12/30

Not yet recruiting

N/A

500

RoW

Peking University Third Hospital

Type 1 Diabetes

01/32

01/32

Active, not recruiting

3

1470

RoW

VABB Elite 10G, BARD 14G CNB

Fudan University

Breast Cancer

12/21

06/22

Recruiting

3

312

RoW

Icaritin, SNG-162, HUACHANSU PIAN, HUACHANSU PIAN（999）

Beijing Shenogen Biomedical Co., Ltd, Chinese Academy of Medical Sciences, NanJing PLA 81 Hospital, Peking University Cancer Hospital & Institute, Beijing Hospital, Guang'anmen Hospital of China Academy of Chinese Medical Sciences, Jinan Central Hospital, Linyi Tumour Hospital, The First Affiliated Hospital of Anhui Medical University, Anhui Provincial Hospital, The First Affiliated Hospital with Nanjing Medical University, The Affiliated Tumor Hospital of Nantong University, Nantong, Jiangsu Province, China, Nanfang Hospital of Southern Medical University, First People's Hospital of Foshan, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Hebei Medical University Fourth Hospital, The First Hospital of Jilin University, Haikou People's Hospital, Fudan University, West China Hospital, Chongqing Traditional Chinese Medicine Hospital, Chifeng Municipal Hospital, The Affiliated Hospital of Hangzhou Normal University, The First Affiliated Hospital of Zhengzhou University, Guilin Medical University, China, The Third Xiangya Hospital of Central South University, Yunnan Provincial Hospital of Traditional Chinese Medicine, The Sixth People's Hospital of Shenyang

Advanced HBV-Related Hepatocellular Carcinoma (HCC)

12/22

12/22

Not yet recruiting

3

542

RoW

TQB2102 for Injection, Chemotherapy drug (Capecitabine/Paclitaxel/Albumin Paclitaxel)

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Breast Cancer

01/27

12/28

Recruiting

3

210

RoW

Fulvestrant, Experimental group, Capecitabine Oral Product, Active Comparator control group

Herui Yao

Metastatic Breast Cancer

05/25

05/30

Enrolling by invitation

N/A

30

RoW

aerobic exercise

First Hospital of Jilin University

Parkinson's Disease, Physical Exercise

10/21

10/21

Recruiting

N/A

500

RoW

SonoVue

Second Affiliated Hospital, School of Medicine, Zhejiang University, Tianjin Third Central Hospital, Sichuan Provincial People's Hospital, Fujian Cancer Hospital, Shandong Jining No.1 People's Hospital, General Hospital of Ningxia Medical University, Beijing Hospital, Red Cross Hospital, Hangzhou, China, Zhejiang Cancer Hospital, Shengjing Hospital

Hepatocellular Carcinoma

12/23

12/23

Not yet recruiting

N/A

1500

RoW

adrenal venous sampling

Chinese Academy of Medical Sciences, Fuwai Hospital

Hyperaldosteronism

12/26

12/26

Not yet recruiting

N/A

90

NA

electropuncture

Ying Zhang, Peking Union Medical College Hospital, Beijing Obstetrics and Gynecology Hospital, Peking University Cancer Hospital & Institute, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Sichuan Cancer Hospital and Research Institute, Shanghai University of Traditional Chinese Medicine, Hunan Cancer Hospital, Chongqing University Cancer Hospital

Cervical Cancer

11/26

11/26

Not yet recruiting

N/A

1000

RoW

Continuous Glucose Monitoring System (GX-01S)

Nanjing First Hospital, Nanjing Medical University

Type1 Diabetes Mellitus

10/26

06/27

Recruiting

4

1312

RoW

GV-971, Placebo

Green Valley (Shanghai) Pharmaceuticals Co., Ltd.

Alzheimer's Disease

06/29

12/29

Active, not recruiting

3

551

RoW

HTD1801, berberine ursodeoxycholate, Placebo

HighTide Biopharma Pty Ltd

Type 2 Diabetes Mellitus

03/25

12/25

Active, not recruiting

3

274

RoW

BPI-16350, placebo, Fulvestrant

Betta Pharmaceuticals Co., Ltd.

Breast Cancer

12/23

07/25

Active, not recruiting

3

15374

Europe, Canada, Japan, US, RoW

Tirzepatide, LY3298176, Placebo

Eli Lilly and Company

Obesity, Overweight

10/27

10/27

Recruiting

2

144

RoW

Iguratimod, Placebo

Jiangsu Simcere Pharmaceutical Co., Ltd.

Primary Sjögren Syndrome

04/22

06/22

Recruiting

2

261

RoW

Recombinant humanized IL-17A Monoclonal Antibody（JS005）, Placebo（JS005）

Shanghai Junshi Bioscience Co., Ltd., Sponsor GmbH

Ankylosing Spondylitis

02/25

10/25

Recruiting

2

64

RoW

GT101 injection, Gemcitabine injection

Grit Biotechnology

Adult

01/27

01/27

Recruiting

2

83

RoW

Efbemalenograstim Alfa

Shandong University, Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Ovarian Cancer, Cervical Cancer

06/26

12/26

Recruiting

1

40

RoW

TQB2858 injection

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Advanced Cervical Cancer

05/23

07/23

Recruiting

1

216

RoW

BAT8006 for Injection, Exatecan conjugate of recombinant humanized monoclonal antibody against folate receptor α for injection

Bio-Thera Solutions

Advanced Solid Tumors

12/24

12/25

Recruiting

N/A

150

RoW

Methylprednisolone, IVIG, other basic supportive treatment

Children's Hospital of Fudan University, Shanghai Children's Hospital, Shanghai Children's Medical Center

Henoch-Schönlein Purpura

10/24

10/25

Recruiting

N/A

100000

RoW

Capital Medical University, Beijing Tiantan Hospital, Beijing Chao Yang Hospital, Fu Xing Hospital, Capital Medical University, Peking Union Medical College Hospital, Peking University First Hospital, Peking University Third Hospital, Chinese PLA General Hospital, China-Japan Friendship Hospital, Beijing Geriatric Hospital, The First Affiliated Hospital of Dalian Medical University, Fujian Medical University Union Hospital, Guangzhou Psychiatric Hospital, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, First Affiliated Hospital of Guangxi Medical University, The Affiliated Hospital Of Guizhou Medical University, Handan Central Hospital, Hebei General Hospital, First Hospital of Shijiazhuang City, Tangshan Worker's Hospital, Hunan Provincial People's Hospital, Kaifeng Central Hospital, People's Hospital of Zhengzhou University, Wuhan University Zhongnan Hospital, First Affiliated Hospital of Harbin Medical University, Tongji Hospital, People's Hospital Affiliated Hubei Medical University, The Third Xiangya Hospital of Central South University, Xiangya Hospital of Central South University, The First Hospital of Jilin University, China-Japan Union Hospital, Jilin University, Subei People's Hospital of Jiangsu, Nantong University Affiliated Hospital, Mineral General Hospital, Xuzhou, Jiangxi Provincial People's Hopital, Anshan Central Hospital, The Affiliated Zhongshan Hospital of Dalian University, First Hospital of China Medical University, Baotou Central Hospital, General Hospital of Ningxia Medical University, The People's Hospital of Ningxia, The Affiliated Hospital of Qingdao University, The 960th Hospital of PLA, Qilu Hospital of Shandong University, Qilu Hospital of Shandong University (Qingdao), Shandong Provincial Hospital, Qingdao Municipal Hospital, The First Affiliated Hospital of Shanxi Medical University, Tang-Du Hospital, First Affiliated Hospital Xi'an Jiaotong University, Ruijin Hospital, RenJi Hospital, Shanghai Changzheng Hospital, Affiliated Hospital of North Sichuan Medical College, Tianjin Huanhu Hospital, Tianjin Medical University General Hospital, Traditional Chinese Medicine Hospital of Xinjiang Autonomous Region, Ningbo Medical Center Lihuili Hospital, First Affiliated Hospital of Wenzhou Medical University, First Affiliated Hospital of Zhejiang University, Shao Yifu Hospital of Zhejiang Medical University, Zhejiang Provincial People's Hospital, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University, The Second Affiliated Hospital of Chongqing Medical University, The First Affiliated Hospital of Anhui Medical University, People's Hospital of Chongqing, Dongfang Hospital Beijing University of Chinese Medicine, Zigong No.1 Peoples Hospital

Mild Cognitive Impairment(MCI), Alzheimer Disease, Late Onset, Familial Alzheimer Disease (FAD), Vascular Dementia (VaD), Normal Control, Non-Alzheimer Degenerative Dementia

01/38

01/38

Recruiting

2

40

US

Cisplatin-based Radiation Therapy, Cisplatin Chemotherapy

Cedars-Sinai Medical Center

HPV Positive Oropharyngeal Squamous Cell Carcinoma

12/26

12/29

Active, not recruiting

1

160

US

CG-806, Luxeptinib

Aptose Biosciences Inc.

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Non-Hodgkin's Lymphoma

12/24

05/25